We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Top Buys

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$73.5M
2
RCAP
RCS CAPITAL CORPORATION CLASS A COM
RCAP
+$39.5M
3
VISN
Vistance Networks Inc
VISN
+$37.4M
4
MHK icon
Mohawk Industries
MHK
+$36.3M
5
ARMK icon
Aramark
ARMK
+$31.5M

Top Sells

Rank Stock Value
1
PF
Pinnacle Foods, Inc.
PF
+$34.3M
2
PFE icon
Pfizer
PFE
+$32.3M
3
ROK icon
Rockwell Automation
ROK
+$31.2M
4
FRX
FOREST LABORATORIES INC
FRX
+$31.1M
5
NFLX icon
Netflix
NFLX
+$28.2M

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYNO
376
DELISTED
Cynosure, Inc. Class A
CYNO
$514K 0.01%
+24,187
New +$559K
ALIM
377
DELISTED
Alimera Sciences
ALIM
$508K 0.01%
5,667
-9,750
-63% -$866K
SMC
378
Summit Midstream
SMC
$419M
$500K 0.01%
655
– –
PETX
379
DELISTED
Aratana Therapeutics, Inc.
PETX
$500K 0.01%
32,017
-48,876
-60% -$693K
TLOG
380
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$489K 0.01%
82,943
+7,284
+10% +$41.3K
DAL icon
381
Delta Air Lines
DAL
$60.1B
$387K 0.01%
10,000
-371,377
-97% -$14M
LEJU
382
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$345K 0.01%
+3,294
New +$360K
TOUR
383
Tuniu
TOUR
$55.6M
$335K 0.01%
+1,900
New +$285K
FATE icon
384
Fate Therapeutics
FATE
$326M
$322K 0.01%
+51,077
New +$360K
TLMR
385
DELISTED
TALMER BANCORP INC (MI)
TLMR
$320K 0.01%
+23,231
New +$320K
CYTK icon
386
CALL
Cytokinetics
CYTK
$10.4B
$314K 0.01%
65,789
– –
CBIO
387
Crescent Biopharma
CBIO
$626M
$257K 0.01%
305
-447
-59% -$445K
FNCX
388
DELISTED
Function(x) Inc.
FNCX
$239K 0.01%
+2,760
New +$270K
AKAO
389
DELISTED
Achaogen Inc
AKAO
$196K ﹤0.01%
14,049
-29,768
-68% -$417K
QURE icon
390
uniQure
QURE
$3.22B
$172K ﹤0.01%
12,620
-38,311
-75% -$417K
CYTK icon
391
Cytokinetics
CYTK
$10.4B
$164K ﹤0.01%
34,413
-228,155
-87% -$1.39M
VCRA
392
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$158K ﹤0.01%
+12,006
New +$164K
CYHHZ
393
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$31K ﹤0.01%
458,711
+40,848
+10% +$2.66K
AA icon
394
Alcoa
AA
$13.2B
– –
-29,130
Closed -$901K
AAPL icon
395
CALL
Apple
AAPL
$4.57T
– –
-3,052,000
Closed -$58.5M
AL
396
DELISTED
Air Lease Corp
AL
– –
-330,737
Closed -$12.3M
ANIP icon
397
ANI Pharmaceuticals
ANIP
$1.78B
– –
-30,907
Closed -$969K
APAM icon
398
Artisan Partners
APAM
$3.02B
– –
-222,562
Closed -$14.3M
APD icon
399
Air Products & Chemicals
APD
$67.6B
– –
-54,670
Closed -$6.02M
AVB icon
400
AvalonBay Communities
AVB
$26.8B
– –
-57,318
Closed -$7.53M
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.